Smartstop Self Storage REIT (NYSE:SMA) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Smartstop Self Storage REIT (NYSE:SMA) issued its earnings results on Wednesday. The healthcare company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01, Zacks reports. Smartstop Self Storage REIT had a negative return on equity of 0.16% and a negative net margin of 0.59%. Smartstop Self Storage REIT updated its FY 2026 guidance to 1.940-2.040 EPS.

Smartstop Self Storage REIT Stock Performance

SMA stock traded up $1.03 during midday trading on Wednesday, hitting $32.03. The company’s stock had a trading volume of 798,272 shares, compared to its average volume of 862,904. The stock’s 50-day moving average price is $31.85 and its 200 day moving average price is $32.55. The company has a quick ratio of 5.87, a current ratio of 5.87 and a debt-to-equity ratio of 0.86. Smartstop Self Storage REIT has a 1 year low of $29.42 and a 1 year high of $39.77. The stock has a market cap of $1.77 billion and a price-to-earnings ratio of -86.57.

Smartstop Self Storage REIT Increases Dividend

The firm also recently declared a monthly dividend, which will be paid on Monday, June 15th. Investors of record on Friday, May 29th will be issued a dividend of $0.1359 per share. This represents a c) dividend on an annualized basis and a yield of 5.1%. This is an increase from Smartstop Self Storage REIT’s previous monthly dividend of $0.13. The ex-dividend date is Friday, May 29th. Smartstop Self Storage REIT’s dividend payout ratio is -440.54%.

Analyst Ratings Changes

Several equities research analysts have recently commented on SMA shares. JPMorgan Chase & Co. decreased their price objective on Smartstop Self Storage REIT from $35.00 to $32.00 and set an “underweight” rating for the company in a report on Monday, March 23rd. Wells Fargo & Company reduced their price objective on shares of Smartstop Self Storage REIT from $33.00 to $30.00 and set an “equal weight” rating for the company in a report on Thursday, April 16th. Truist Financial decreased their price objective on Smartstop Self Storage REIT from $39.00 to $38.00 and set a “buy” rating for the company in a report on Tuesday, January 20th. Zacks Research lowered Smartstop Self Storage REIT from a “hold” rating to a “strong sell” rating in a research report on Friday, January 30th. Finally, Stifel Nicolaus reduced their target price on shares of Smartstop Self Storage REIT from $39.50 to $38.50 and set a “buy” rating for the company in a research note on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $36.94.

Institutional Investors Weigh In On Smartstop Self Storage REIT

A number of hedge funds have recently made changes to their positions in the business. Corient Private Wealth LLC purchased a new position in shares of Smartstop Self Storage REIT in the 4th quarter worth about $216,000. Invesco Ltd. increased its holdings in Smartstop Self Storage REIT by 9.3% during the fourth quarter. Invesco Ltd. now owns 22,940 shares of the healthcare company’s stock worth $710,000 after buying an additional 1,956 shares during the last quarter. Onyx Bridge Wealth Group LLC purchased a new stake in Smartstop Self Storage REIT during the fourth quarter worth about $464,000. NewEdge Advisors LLC bought a new stake in Smartstop Self Storage REIT in the fourth quarter worth about $82,000. Finally, XTX Topco Ltd bought a new stake in Smartstop Self Storage REIT in the fourth quarter worth about $1,059,000.

Smartstop Self Storage REIT Company Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.